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The effect of growth factors on the cytochrome P-450 (CYPIAl) gene expression was studied in primary mouse hepatocytes. Of the three growth 
factors used, i.e. epidermal growth factor (EGF), transforming growth factor a (TGFa) and insulin, only EGF or TGFa completely blocked 
CYPIAl expression in the presence of the CYPIAl inducer 3methylcholanthrene (3-MC). This repression was not linked to cell cycle progression 
of the hepatocyte because insulin was active to induce ‘early immediate genes’ and DNA replication as well as EGF/TGFa but failed to suppress 
CYPIAl expression, A specific EGF/TGFa receptor-mediated function may repress CYPIAl gene expression and contribute to the acquisition 
of a xenobiotic drug resistance. phenotype.. 
Hepatocyte; Growth factor; Cytochrome P-450 gene regulation 
1. INTRO~U~ION 
Exposure of rats to carcinogens followed by tumor 
promoters induces macroscopic liver foci referred to as 
hyperplastic liver nodules [ 1,2]. These liver cell popula- 
tions are regarded as preneoplastic and as possibly 
diploid progenitor cells of hepatocellular carcinoma 
showing significant changes in the proliferation pattern 
compared to normal hepatocytes [3,4]. Furthermore, 
the altered growth state is accompanied by rapid loss of 
nearly all cytochrome P-450 (CYP)dependent activities 
leading to the xenobiotic drug resistance phenotype 
15-71. Until now, there are no data which could 
demonstrate a direct link between the state of prolifera- 
tion of the hepatocyte and the mechanism of CYP 
repression. Recent results could show that TGFcr acts as 
an autocrine 8rowth factor in the regeneration step of 
hepatocytes after hepatectomy [8] and in hepatoma for- 
mation [9]. The process of liver regenerative growth in 
many aspects resembles the events in hyperplastic liver 
growth [lO,l l] suggesting that TGFa, may play a crucial 
role also in CYP repression. In the present study we us- 
ed an in vitro system of primary mouse hepatocytes 
which can be gro~h-s~ulated by addition of growth 
factors such as EGF, TGFa! and insulin. The expression 
of ‘immediate early genes’ like c-fos, c-jr&r or c-myc 
followed by DNA replication was found to be induced 
by EGF, TGFa! or insulin to a similar extent. However, 
CYPIAl gene expression was inhibited only by an 
EGF/TGFa receptor-mediated function. 
2. MATERIALS AND METHODS 
Adult C57BL6 mouse hepatocytes were isolated by collagenase per- 
fusion and differential centrifugation [12]. Cells were cultured in 
serum-free MX-82 medium as described [13]. For Northern blot 
analysis of oncogene xpression cells were washed and directly lysed 
in the culture dishes by 4 M guanidinium isothiocyanate/2-mercap- 
toethanol and total RNA was isolated by CsCl gradient centrifugation 
1141. The c-fos-specific probe was a 1.1 kb PstI fragment of pv-&sl 
[is], the c-myc-specific probe a v-myc (MC29) 1.2 kb PsfI insert of 
pMC-Pst [16]. Northern blot analysis was described in detail 
elsewhere 1171. DNA probes were labeled with [32P]dCTP by random 
oligonucleotide priming [ 18 1. 
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Cytochrome P-450 (CYPIAl) was purified from @- 
naphthoflavone-induced rat liver microsomes as described [ 191. The 
antibody was produced in rabbits and purified by antigen-coupled 
Sepharose-4B (Pharmacia) using usual procedures. Hepatocyte 
microsomes were prepared by differential centrifugation [20]. 
Samples of 25 & microsomal proteins were subjected to SDS-gel elec- 
trophoresis (SDS-PAGE) after denaturation by boiling according to 
Laemmli [21]. Proteins were transferred electrophoretically to 
nitrocellulose membranes (Amersham) by semi-dry blotting and in- 
cubated with anti-rat CYPIAI antibody [IS] in a I:500 dilution. 
Detection was achieved with secondary anti-rabbit [‘2sIJIg-F(ab)2 
(Amersh~). In case of FOS analysis Western blots were carried out 
with an epitope-specific FOS anti-serum o-fos-454 [22] after im- 
munoprecipitation of FOS from whole ceil lysates with the same an- 
tibody followed by detection with Auro probe BL plus anti-rabbit IgG 
(Janssen) and silver enhancement. 7-Ethoxyresorutin-0-deethylase 
activity (EROD) was measured in microsomes [23], while CYP con- 
tent was determined by CO difference spectroscopy [24]. 
[3H]Thymidine incorporation into DNA was measured as described 
[13]. Insulin and rEGF was purchased from Boehringer (Mannheim, 
FRG), while TGFo, synthetic, was from Bachem (Basel, 
Switzerland). 
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Table I 
Suppression of CYP activities by EGF or TGFo 
Hepatocyte culture CYP + SD EROD f SD 
(nmol CYP/mg protein) (nmol EROD/min/mg protein) 
October 1990 
0 h, control 0.83 -t 0.05 0.13 f 0.01 
3 days, control 0.17 f 0.02 0.02 f 0.01 
3 days, 3-MC 0.46 + 0.03 0.98 * 0.02 
3 days, 3-MC/EGF 0.18 * 0.02 0.04 f 0.01 
3 days, 3-MC/TGFo 0.16 f 0.02 0.03 f 0.01 
Hepatocytes were cultured with 3-MC or without (control) in the presence of EGF (lo-’ M) 
or TGFn (10-s M) for the times as indicated. CYP and EROD activities were obtained from 
4 independent experiments. 
3. RESULTS AND DISCUSSION 
3.1. Effects of growth factors on CYPIAI expression 
In the present serum-free primary culture system, the 
content of total CYP decreased to 20% of that in 
freshly prepared cells within 3 days (Table I). However, 
in the presence of 3-methyl~holanthrene (3-MC), a 
classical inducer of CYPIAl [25,26], the CYP content 
decreased only to 50% of the original level, and a 
drastic increase in the ethoxyresorufin-0-deethylase ac- 
tivity (EROD), which is specific for CYPIAl activity 
[23], was observed. This is due to the induction of 
CYPIAl as confirmed by Western blot analysis (Fig. 1). 
Similar decrease of total CYP content and induction of 
CYPIAl by 3-MC have been published using rat 
hepatocyte primary culture 1271. In our system CYPIAl 
induction was not significantly affected in the presence 
of insulin (lo-* M). However, EGF and EGF in com- 
bination with insulin (Fig. 1) or TGFo alone (Table I) 
almost totally suppressed the induction of CYPIAl by 
Fig. 1. Western blot analysis of CYPIAl expression after 
3-methylcholanthrene (3-MC) induction in vitro. Hepatocytes were 
treated with 3-MC (3 @I) for 1 day (lanes 1,2), 2 days (lanes 3-6) or 
3 days (lanes 7-10) in the absence (- ) or presence of lo- ’ EGF (E), 
lo- 6 M insulin (I) or EGF and insulin (Ef). Western blot analysis was 
performed as described in section 2. 
3-MC. In regenerating liver [28], in preneoplastic liver 
lesions [28] and in hepatoma tissues of rodent and man 
[29,30] low levels of CYP-dependent activities were 
found. Furthermore, also the induction of CYP is sup- 
pressed in regenerating liver 1311. TGFtv binds to the 
EGF receptor and may be directly involved in the con- 
trol of liver size under regenerative growth [9]. Recent 
data suggest also a direct role of TGFa! in the autocrine 
growth of hepatoma [S]. TGFar may, therefore, be in- 
volved in the suppression of CYPIAl gene expression 
under these conditions. 
3.2. afects of growth factors on proto-oncogene 
expression and DNA replication in primary hepa- 
tocyte cultures 
Insulin at a concentration of 10 - ’ M leads to a tran- 
sient expression of c-fos in primary mouse hepatocyte 
culture when cells were growth-arrested for 48 h. The 
highest accumulation of transcripts is observed around 
10 min followed by a rapid decline (Fig. 2A). The c-fos 
expression precedes the c-myc expression which peaks 
around 1 h and declines to barely detectable levels at 2 
h (Fig, 2B). EGF and insulin at lo- * M are comparably 
effective in the accumulation of FOS protein. However, 
EGF elicited a nearly two times higher response which 
is further potentiated by the combination of EGF and 
insulin (Fig. 3A). Parallel to the induction of c-fos the 
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Fig. 2. Northern blot analysis of c-fos and c-myc transcripts in 
primary mouse hepatocytes after induction with insulin. Adult mouse 
hepatocytes were growth-arrested for 48 h in MX-82 medium. insulin 
(lo- * M) was added and the cells were harvested at the times as in- 
dicated. 20 JAM of total RNA were loaded per lane, separated on gfyox- 
al agarose gels and subs~uently blotted to nylon filters and hybridiz- 
ed with a v-fos specific probe (A) or with a v-myc specific probe (3). 
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Fig. 3. Western blot analysis of FOS and .IWN/p3’ expression in primary mouse hepatocytes after induction by different growth factors. Adult 
mouse hepatocytes were growth-arrested in ar&ine-free MX-82 medium for 72 h and then stimulated for 1 h with the growth factors as indicated. 
(A) Cells were lysed, c-fos protein (Fos was immunopr~pitated with cvzfos 454 antibody and ~rn~o~p~exes bound to protein A Sepharose 
4B (Pharmacia). Western blot a&y&s was carried out using a f :IooO dihztiou of a-@ 454 and Auro Frohe 3L pius {Jamsen) anti-rabbit IgG for 
detection foRowed by silver enhaucemenl. Cells were stimtited with EGF (iO-* M, iane 41, in&in (INS) (fQe6 M, lane 2; 10-s M, Iane 3) or 
EGF and insulin (10-s M, each respectively, lane I). Unsdm~ated control (c) is shown in Iane 5, while EGF ff0-8 M} stimuIated &is im- 
munoprecipitated with rabbit pre~mmu~oseNm 455 is shown in lane 6. Molecular mass markers are shown in kDa. (B) After I h growth factor 
stimulation with EGF (10-’ M) or insulin (IO-* M) ceils were pulse-labeled for I.5 min with [“Slmethionine (300 &Zi/lO cm dish/5x 10’ c&s). 
After the labelling period, the cells were iysed in RIPA buffer and cleared supernatants were incubated with cu-fos 454 antibody. Im- 
munoprecipitates were analyzed using 12% SDS-polyacrylamide gels followed by autoradiography. 
@+related gene product FRA-1 at 43 kDa is expressed 
[30]. Similar effects are seen in the induction of 
JUZV/P3g-protein which coprecipitates with FUS in the 
immuno-analysis (Fig_ 33). Reinitiation of DNA syn- 
thesis after a 48 h growth arrest of the hepat~~e in 
response to growth factors (10-s &I) was determined by 
r3HJthymidine incorporation into DNA and expressed 
in cpm x ld/2.5 x ld cells +: SD (no addition: 12.8 t 
2.1; EGF: 59.8 + 3.8; insulin: 36.5 4 4.5; EGFlin- 
sulin: 68.3 f 2.5). 
Previous studies failed to show that insulin can in- 
duce c-fos expression in primary rat hepatocytes [ 111. It 
is well established that insulin is one important iiver- 
specific growth factor and necessary during the process 
of liver regeneration 1311. Our data indicate that EGF 
and insulin are equally potent he~atotrophi~ mitogens 
in mouse hepatocytes in primary culture and can 
simulate mechanisms of liver regeneration in vivo [3 1 ] I 
These growth factors activate *early response’ genes like 
c-f&, c_iun and c-m_~c which possibly act cooperatively 
in the competence phase of the hepatocytes as 
demonstrated in vivo during liver regeneration [9]. 
Although EGF/TGFo( and insulin are equally potent 
in the activation of proto-oncogenes which is followed 
by mitogenic response, only EGF/TGFa can suppress 
the induction of CYPIAl gene expression in the present 
hepatocyte culture system. The induction of hepatocyte 
DNA replication and proto-oncogene expression in 
vitro is therefore not generally accompanied by an 
altered CYPfAl gene expression, and the growth 
regulatory pathways of the hepatocytes after activation 
of ‘early response’ genes are not directly linked to the 
repression of CYPIAl gene expression. The growth fac- 
tors EGF and TGFar via the EGF receptor may control 
the CYPIAI mediated drug resistance phenot~e of 
hepatocytes during regenerative growth and tumor 
development. 
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